Relationship Between the Levels of Feno, Blood Eosinophils, and the Severity of Exacerbations in Patients With COPDTake-Home Points

Background: Exacerbation risk of patients with COPD is thought to be influenced by type 2 inflammation, with blood eosinophil counts and fractional concentration of exhaled nitric oxide (Feno) as potential biomarkers. Research Question: Are there different associations of blood eosinophils and Feno...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Peter Alter, MD, Henrik Watz, MD, Kathrin Kahnert, MD, Franziska C. Trudzinski, MD, Hubert Wirtz, MD, Tim Speicher, Inge Kokot, Sandra Söhler, PhD, Robert Bals, MD, PhD, Klaus F. Rabe, MD, Emiel F.M. Wouters, MD, Claus F. Vogelmeier, MD, Rudolf A. Jörres, PhD
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-09-01
Saila:	CHEST Pulmonary
Gaiak:	COPD eosinophils exacerbation exhaled nitric oxide (FeNO)
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S294978922500056X
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!